These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3850849)

  • 1. Alterations in plasma and CSF levels of GABA, 5-HT and amino acids in fulminant hepatic failure.
    Singh NK; Thapliyal A; Jain AK; Chansuria JP; Gupta JP; Srivastava PK
    Indian J Gastroenterol; 1985 Oct; 4(4):253-5. PubMed ID: 3850849
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acids in liver failure.
    Zieve L
    Gastroenterology; 1979 Jan; 76(1):219-21. PubMed ID: 758143
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for gamma-aminobutyric acid as the inhibitor of gamma-aminobutyric acid binding in the plasma of humans with liver disease and hepatic encephalopathy.
    Levy LJ; Leek J; Losowsky MS
    Clin Sci (Lond); 1987 Nov; 73(5):531-4. PubMed ID: 3677559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluid.
    Moroni F; Riggio O; Carlà V; Festuccia V; Ghinelli F; Marino IR; Merli M; Natali L; Pedretti G; Fiaccadori F
    Hepatology; 1987; 7(5):816-20. PubMed ID: 3653849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum gamma-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy.
    Minuk GY; Winder A; Burgess ED; Sarjeant EJ
    Hepatogastroenterology; 1985 Aug; 32(4):171-4. PubMed ID: 4054811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oral supplementation of branched-chain amino acids in patients with hepatic failure].
    Yoshida S; Kakegawa T; Mizote H
    Nihon Rinsho; 1991 Nov; 49 Suppl():204-7. PubMed ID: 1665871
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism of branched amino acids in patients with an intact or damaged liver].
    Holecek M; Simek J
    Cesk Fysiol; 1985; 34(6):525-38. PubMed ID: 3910269
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on variation of plasma gamma-aminobutyric acid concentration in rat model of hepatic encephalopathy due to fulminant hepatic failure].
    He X; Luan Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Mar; 23(1):45-8. PubMed ID: 1398623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and serotonin metabolism in hepatic encephalopathy.
    Knell AJ; Davidson AR; Williams R; Kantamaneni BD; Curzon G
    Br Med J; 1974 Mar; 1(5907):549-51. PubMed ID: 4817189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin and glucagon levels in fulminant hepatic failure in man.
    Fiaccadori F; Pedretti G; Ferrari C; Pizzaferri P; Riggio O; Orlandi N; Pezzarossa A
    Dig Dis Sci; 1991 Jun; 36(6):801-8. PubMed ID: 1709604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid gamma-aminobutyric acid levels in dogs with chronic portosystemic encephalopathy.
    Maddison JE; Yau D; Stewart P; Farrell GC
    Clin Sci (Lond); 1986 Dec; 71(6):749-53. PubMed ID: 3791875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc abnormalities in fulminant hepatic failure.
    Canalese J; Sewell RB; Poston L; Williams R
    Aust N Z J Med; 1985 Feb; 15(1):7-9. PubMed ID: 3859271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of the inhibitory neurotransmitter gamma-aminobutyric acid in a rabbit model of fulminant hepatic failure.
    Ferenci P; Covell D; Schafer DF; Waggoner JG; Shrager R; Jones EA
    Hepatology; 1983; 3(4):507-12. PubMed ID: 6862362
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma gamma-aminobutyric acid in experimental fulminant hepatic failure of rats and its diagnostic value in hepatic encephalopathy.
    Wang F; Niu Z; Li ZM
    Chin Med J (Engl); 1990 Mar; 103(3):197-200. PubMed ID: 2114962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased immunoreactive vasoactive intestinal peptide in the cerebro-spinal fluid (CSF) of dogs and monkeys in hepatic failure.
    Ebeid AM; Smith A; Escourrou J; Murray P; Fischer JE
    J Surg Res; 1978 Dec; 25(6):538-41. PubMed ID: 102874
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nutrition and liver insufficiency].
    Soeters PB; Wesdorp RI; Lemmens HA; Greep JM
    Ned Tijdschr Geneeskd; 1979 Oct; 123(40):1742-4. PubMed ID: 492390
    [No Abstract]   [Full Text] [Related]  

  • 17. Branched chain amino acids in heptatic encephalopathy.
    James JH
    Am J Surg; 2002 Apr; 183(4):424-9. PubMed ID: 11975931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal amino acid metabolism in serious liver diseases: branched chain amino acid and aromatic amino acid metabolism].
    Sato Y
    Nihon Rinsho; 1982; 40(4):776-83. PubMed ID: 7098048
    [No Abstract]   [Full Text] [Related]  

  • 19. The pathophysiology of hepatic encephalopathy.
    Faint V
    Nurs Crit Care; 2006; 11(2):69-74. PubMed ID: 16555753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids in liver disease.
    Hagenfeldt L; Eriksson LS; Wahren J
    Proc Nutr Soc; 1983 Sep; 42(3):497-506. PubMed ID: 6361777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.